Physician profile
Christy E Johnson
NPI 1487902623
$3,806.18
in general payments reported to CMS, 2019-2025
32 companies · $714 in 2025
The $714 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $890 · 2022: $623 · 2023: $994 · 2024: $584 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,292.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $945.85 | 2021-2025 | Prolaris, Myrisk |
| Coloplast Corp | $642.94 | 2021-2025 | Speedicath |
| Intuitive Surgical, INC. | $491.41 | 2021 | |
| Teleflex LLC | $301.79 | 2023-2024 | Urolift |
| Pfizer INC. | $274.76 | 2022-2025 | |
| Abbvie INC. | $157.12 | 2022-2024 | |
| Telix Pharmaceuticals | $103.50 | 2025 | Illuccix |
| Antares Pharma, INC. | $98.76 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $97.16 | 2021-2023 | Myrbetriq |
| Myovant Sciences INC. | $74.17 | 2021-2022 | |
| Blue Earth Diagnostics | $59.21 | 2023 | |
| Boston Scientific Corporation | $52.76 | 2022-2023 | Spaceoar Vue System - 10ml |
| Sumitomo Pharma America, INC. | $49.88 | 2023-2024 | Gemtesa |
| Halozyme INC | $48.14 | 2023 | |
| Dentsply Ih INC. | $45.67 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $44.50 | 2022-2025 | |
| Axonics, INC. | $42.28 | 2022-2024 | Axonics |
| Accord Healthcare, INC. | $26.34 | 2022 | |
| Dentsply Ih Ab | $24.85 | 2024 | Lofric |
| Integra Lifesciences Corporation | $24.16 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Endo Pharmaceuticals INC. | $22.57 | 2022 | |
| Tolmar, INC. | $20.87 | 2025 | Jatenzo, Eligard |
| Endo USA, INC. | $20.47 | 2025 | Xiaflex |
| Novartis Pharmaceuticals Corporation | $19.71 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $18.15 | 2021 | |
| Ambu INC. | $17.06 | 2025 | |
| Olympus America INC. | $16.16 | 2023 | Itind System |
| Astrazeneca Pharmaceuticals LP | $14.60 | 2022 | |
| Urovant Sciences INC | $14.30 | 2022 | |
| Janssen Biotech, INC. | $13.81 | 2023 | Erleada |
| Verity Pharmaceuticals INC. | $13.53 | 2025 | Tlando |
| Clarus Therapeutics INC. | $9.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christy Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.